Sierk Poetting - BioNTech COO MD
| 22UA Stock | EUR 113.60 0.10 0.09% |
Insider
Sierk Poetting is COO MD of BioNTech SE
| Age | 50 |
| Phone | 49 6131 9084 0 |
| Web | https://www.biontech.de |
BioNTech Management Efficiency
The company has return on total asset (ROA) of 0.4283 % which means that it generated a profit of $0.4283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7624 %, meaning that it generated $0.7624 on every $100 dollars invested by stockholders. BioNTech's management efficiency ratios could be used to measure how well BioNTech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Stephen MD | Moderna | 47 | |
| Shannon Klinger | Moderna | 52 | |
| Jorn Rosenlund | Nel ASA | N/A | |
| Andreas Boden | Powercell Sweden | 46 | |
| ChuanFu Wang | BYD Company Limited | 57 | |
| James Mock | Moderna | 46 | |
| Yubo Lian | BYD Company Limited | 59 | |
| Filip Smeets | Nel ASA | N/A | |
| Ke Li | BYD Company Limited | 53 | |
| Patrik Brouzell | Powercell Sweden | 45 | |
| Jerh Collins | Moderna | N/A | |
| Anders Soreng | Nel ASA | N/A | |
| LLM LLM | CureVac NV | 52 | |
| Dirk Boever | Powercell Sweden | 49 | |
| Goran Linder | Powercell Sweden | 57 | |
| Malte Greune | CureVac NV | 58 | |
| Hasse Johansson | Powercell Sweden | 70 | |
| Igor MSc | CureVac NV | 54 | |
| Juan Andres | Moderna | 58 | |
| Torbjorn Gustafsson | Powercell Sweden | 47 | |
| Hakon Volldal | Nel ASA | 47 | |
Management Performance
| Return On Equity | 0.76 | |||
| Return On Asset | 0.43 |
BioNTech SE Leadership Team
Elected by the shareholders, the BioNTech's board of directors comprises two types of representatives: BioNTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioNTech. The board's role is to monitor BioNTech's management team and ensure that shareholders' interests are well served. BioNTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioNTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jens Holstein, CFO Board | ||
| Sylke Maas, VP Strategy | ||
| James Ryan, Sr Counsel | ||
| Michael Boehler, MD Communications | ||
| Ryan Richardson, MD Officer | ||
| Sierk Poetting, COO MD | ||
| Pr MD, CoFounder Board | ||
| Ozlem MD, Chief CoFounder | ||
| Sean Marett, Chief Officer |
BioNTech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioNTech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.76 | |||
| Return On Asset | 0.43 | |||
| Profit Margin | 0.56 % | |||
| Operating Margin | 0.68 % | |||
| Current Valuation | 29.68 B | |||
| Shares Outstanding | 242.68 M | |||
| Shares Owned By Insiders | 64.00 % | |||
| Shares Owned By Institutions | 18.41 % | |||
| Price To Earning | 45.99 X | |||
| Price To Book | 2.31 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in BioNTech Stock
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.